ERBB4 and glioblastoma: Total ERBB4 mRNA levels were significantly lower in GBM than in NNB samples (p = 0.002), although a subset of GBM patients, 4/28 (14%), exhibited higher ERBB4 mRNA levels than the mean for NNB samples (Figure 2A).